News

Partnership puts timeline in place for earned revenues VANCOUVER, BC, — (April 8, 2020) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce that further...

Partnership advances time-to-market to under six months VANCOUVER, BC, — (March 24, 2020) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce its entry into...

Management undertakes extensive review of action plan, vendor activities and tour of regional land opportunities VANCOUVER, BC, — (February 27, 2020) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is...

Extensive report details project infrastructure advantages, efficiencies and opportunities from inception to production VANCOUVER, BC, — (January 9, 2020) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to...

Access is key to building brand recognition and added value VANCOUVER, British Columbia, Jan. 02, 2020 Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based business focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales is pleased to announce entry into a Memorandum...

Company goes from strength-to-strength with momentum into 2020 VANCOUVER, British Columbia, Dec. 30, 2019 — Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales is pleased to  extend, on behalf of its executive...

Second property includes acreage, permits and infrastructure with short timeline to production VANCOUVER, BC, — (December 17, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce...

Early reports already impacting decisions resulting in projected process efficiencies and cost savings VANCOUVER, BC, — (December 5, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to...

Approvals pave way for construction as scheduled VANCOUVER, BC, — (November 28, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise that it has received the...

Preparation and planning key to rapid approval VANCOUVER, BC, — (November 21, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise that it has submitted architectural,...